News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
David Planchard Presents Planned OS Results from FLAURA2 Phase III at WCLC25
David Planchard/oncostream.com
Sep 8, 2025, 11:35

David Planchard Presents Planned OS Results from FLAURA2 Phase III at WCLC25

David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at the Gustave Roussy, shared a post on LinkedIn:

“It was an honor to present, on behalf of the co-investigators, the planned OS results from FLAURA2 ph III at WCLC25. These results confirm a shift in our first-line practice for our EGFRm patients, marking the first time a study has achieved a significant benefit mOS of 4Y.”

David Planchard

David Planchard

More posts featuring David Planchard on OncoDaily.

cancer David Planchard FLAURA2 OncoDaily Oncology WCLC25
Special Coverage
Science
Sep 8, 2025, 11:35
David Planchard Presents Planned OS Results from FLAURA2 Phase III at WCLC25
Voices
Sep 8, 2025, 11:33
Sewanti Limaye: Honored to Co-Chair EGFR+ Session at WCLC 2025
Positive
Sep 8, 2025, 11:29
Celebrating Excellence at Cancer Institute NSW: September Staff Awards
Voices
Sep 8, 2025, 11:28
Douglas Flora: Minimal Residual Disease Beyond the Smoke - How We're Using Science to Find What's Left Behind 
Voices
Sep 8, 2025, 11:21
Rami Manochakian Shares MARIPOSA Study Results Presented at WCLC25
Voices
Sep 8, 2025, 11:19
Sendurai Mani: Farewell to Dr. David Baltimore, a Pioneer and Inspiration
Voices
Sep 8, 2025, 11:11
Ilana Schlam: Free NEJM CME Course on Advanced ER+/HER2− Breast Cancer Treatments
Insight
Sep 8, 2025, 11:00
Gevorg Tamamyan: A Story Everyone Must Read
Insight
Sep 8, 2025, 10:52
WCLC25: Insights and Highlights from Dr. Stephen Liu
Voices
Sep 8, 2025, 09:53
David Planchard Highlights FLAURA2 OS Benefit Discussion at WCLC 2025
Science
Sep 8, 2025, 09:46
Amol Akhade: WCLC25 Highlight - HARMONi-A Trial in EGFR-mutant NSCLC
Science
Sep 8, 2025, 09:35
Drew Moghanaki: Shift in Radiation Therapy Intent for NSCLC Over the Past Decade